Supaveda · Ingredient Spotlight
Bhringaraj
Eclipta alba Hassk. — syn. Eclipta prostrata L.
Also known as: False Daisy · Kesharaja · Kesharanjana · Markava · Bhringaraja · Tekaraja · Yerba de Tago · Han Lian Cao
Crush a fresh leaf of Bhringaraj between your fingers and it produces an ink so deeply black it has been used across South Asia for millennia to darken hair and beards. That same blackening pigment — a concentration of melanin-stimulating coumestan compounds — is the biochemical basis for one of Ayurveda's most consistent clinical observations: this small, unremarkable-looking white-flowered herb regrows, darkens, and strengthens hair more powerfully than almost any plant known to traditional medicine.
A small annual herb of the daisy family (Asteraceae) found growing in moist waste ground, riverbanks, and paddy fields across the Indian subcontinent, South-East Asia, South America, and the southern United States, Eclipta alba (syn. E. prostrata) is simultaneously Ayurveda's foremost hair herb and its most important liver herb — a dual classification that is not coincidental: classical physicians understood that healthy hair growth depends on a healthy liver to process the hormones that regulate the hair cycle. Modern pharmacology has confirmed this dual action with extraordinary precision. A peer-reviewed in vivo study published in Archives of Dermatological Research (PMC6374973) demonstrated that E. prostrata extract outperformed topical minoxidil in hair growth promotion in mice — inducing the anagen (growth) phase faster, producing more follicles, and through a completely different molecular mechanism. 1 And a 2024 multi-omics study (PMC11035064) confirmed that wedelolactone — Bhringaraj's primary active coumestan — significantly ameliorates non-alcoholic fatty liver disease (NAFLD) through spatial metabolomics and transcriptomics-validated mechanisms. 2
Than
Minoxidil
👑 The King of Hair — Why Classical Physicians Named It Kesharaja
Sanskrit medical names in Ayurveda are rarely hyperbolic — they encode a clinical observation distilled from generations of practice. Kesharaja means literally "King of Hair" (kesh = hair; raja = king). Bhringaraja means "Ruler of the Bees" — the small white flowers attract bees, but the name also encodes the herb's capacity to make hair as thick and dark as a bee's body. Markava means "that which marks" — a reference to the black ink the crushed plant produces, used in classical India both for dyeing grey hair black and as a writing ink. Every Sanskrit synonym encodes a therapeutic identity, and they are unanimous: this is the supreme herb for hair. 3
The pharmacological story behind this classification is now well understood. Hair follicles cycle through four phases: anagen (growth, lasting 2–7 years), catagen (regression, 2–3 weeks), telogen (rest, 3 months), and exogen (shedding). The primary cause of male and female pattern hair loss (androgenetic alopecia) is the progressive shortening of anagen and miniaturisation of follicles — driven by dihydrotestosterone (DHT) produced by 5-α-reductase acting on testosterone. Bhringaraj addresses this cycle at three distinct points: it induces anagen via FGF-7 upregulation (the key signal for follicle entry into growth phase); it prolongs anagen by downregulating FGF-5 (the signal that terminates growth phase) and TGF-β1 (which drives follicle into regression); and it inhibits 5-α-reductase (reducing DHT-driven miniaturisation) via β-sitosterol. 14 Meanwhile, wedelolactone's hepatoprotective and NF-κB-inhibiting action addresses the hormonal detoxification and systemic inflammatory dimension of hair loss that topical treatments alone cannot reach — the pharmacological basis for the classical Ayurvedic principle that hair health begins in the liver.
At a Glance — Key Evidence-Backed Benefits
Traditional Ayurvedic & Classical Uses
Bhringaraj is documented in the Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, and all major Ayurvedic Nighantus as the primary single herb for hair health, and simultaneously as one of the foremost liver (Yakrit) herbs. It appears in more classical formulations for hair care than any other single herb — including the renowned Bhringaraj Taila (Bhringaraj oil), Neelibhringadi Taila, Bhringarajasava (fermented preparation), and Bhringaraj Ghrita — alongside its use in polyherbal formulas for liver disease such as Yakritplihantak Churna. 3
The classification of the same herb as both the "King of Hair" and a primary liver Rasayana is not accidental dualism — it reflects classical Ayurvedic understanding of the liver's role in hormone metabolism and tissue nourishment. In Ayurvedic physiology, the liver is the seat of Ranjaka Pitta — the fire that colours the blood and, by extension, colours the hair. When liver function is impaired, hair loses pigment (premature greying) and falls. Bhringaraj's role as a liver Rasayana directly supports hair health by maintaining the metabolic environment within which healthy hair follicles can function — a pharmacological logic that modern hepatology validates: liver disease is an established cause of hair loss, and testosterone/DHT are metabolised in the liver. 3
Ayurvedic Properties (Guna)
The sweet post-digestive effect (Madhura Vipaka) alongside heating potency (Ushna Veerya) is the pharmacological signature of a Rasayana herb — one that simultaneously stimulates metabolism (heating) and nourishes tissues (sweet vipaka). This combination is why Bhringaraj is classified as a hair Rasayana rather than merely a hair treatment: it works upstream at the metabolic and tissue-building level, not merely by topical application.
Conditions Traditionally Treated
- Hair loss (Khalitya) and premature greying (Palitya) — the primary indications; both as oral Rasayana and topical oil application
- Liver disease (Yakrit Vikara) — jaundice, hepatitis, cirrhosis; Bhringaraj is described as the best drug for treating liver cirrhosis and infective hepatitis in classical texts
- Spleen disorders (Pliha Roga) — splenic enlargement; liver-spleen axis disease common in tropical infections
- Skin diseases (Kushtha) — particularly conditions related to blood and liver toxicity; detoxifying action
- Eye health (Netra Roga) — classical Rasayana for maintaining vision and eye health; includes dark circles under eyes (liver Pitta excess)
- Memory and cognition — Medhya (brain tonic) classification; wedelolactone's acetylcholinesterase inhibitory activity (emerging research)
- Teeth and bones — classical description as preventing premature tooth loss and bone weakness; rejuvenative for hard tissues
- Respiratory conditions — asthma and cough; E. prostrata extract reduces respiratory resistance and eosinophilia in allergen-induced models comparable to dexamethasone
- Wound healing and bleeding disorders — astringent and haemostatic properties; topical application to wounds
- Anti-ageing (Rasayana) — described in classical texts as an herb that prevents ageing while renewing hair, teeth, and bones; the epitome of Rasayana action
Key Active Compounds
The pharmacological activity of Eclipta alba is dominated by its unique coumestan compounds — particularly wedelolactone — which are responsible for both the hepatoprotective and, through androgen receptor modulation, aspects of the hair growth activity. The plant also contains triterpene saponins, flavonoids, phytosterols, alkaloids, and polypeptides, each contributing to its exceptionally broad therapeutic profile. 3
Primary Bioactive Constituents
How Bhringaraj Works — Four Therapeutic Mechanisms
Bhringaraj's pharmacological breadth across hair biology and liver physiology is explained by four distinct but connected mechanisms that together address the full spectrum of hair loss causes and liver vulnerability simultaneously — the pharmacological basis for its classical dual classification as Kesharaja and liver Rasayana. 12
Bhringaraj's Four Core Therapeutic Mechanisms
What the Research Says
The key pharmacological study establishing Bhringaraj's hair growth mechanism was published in Archives of Dermatological Research (PMC6374973). C57BL/6 mice — the gold standard model for studying hair growth, as their coats turn visibly darker as follicles enter anagen — were divided into four groups: control (saline), 3% topical minoxidil, low-dose oral E. prostrata extract (1 mg/day), and high-dose oral E. prostrata extract (10 mg/day). Dorsal hair was depilated to synchronise follicles into telogen before treatment. 1
The results were remarkable: after 14 days, hair growth and skin darkness were more prominent in both EP groups than in both control and minoxidil groups. Histological examination confirmed dermal papilla was enclosed (resting state) in controls, while hair shafts were present through hair canals in minoxidil and both EP groups. Mechanistic analysis in human dermal papilla cells (HDPs) showed EP extract significantly increased FGF-7 expression — the key signalling protein that drives follicle transition from telogen to anagen. It simultaneously downregulated FGF-5, the signal that terminates anagen, and activated mTOR signalling in HDPs, enhancing cell proliferation. In the complementary Begum et al. study (Int J Mol Med, 2015), E. alba specifically promoted hair matrix keratinocyte proliferation while downregulating TGF-β1 expression — the regression-inducing signal — confirming that Bhringaraj does not merely start hair growth but actively prolongs it. The petroleum ether extract study (Singh et al.) further confirmed 68% anagenic follicles with PE extract versus negligible in control, with HPLC analysis identifying wedelolactone (1.9% w/w) and β-sitosterol (4.56% w/w) as the primary active constituents.
Androgenetic alopecia — male and female pattern hair loss — is driven primarily by dihydrotestosterone (DHT), produced when the enzyme 5-α-reductase converts testosterone. DHT miniaturises genetically susceptible follicles progressively until they no longer produce terminal hair. The pharmaceutical treatment for this — finasteride (Propecia) — works by inhibiting 5-α-reductase type II; dutasteride inhibits both type I and type II. Both carry risk of persistent sexual side effects in a proportion of users. 4
A 2023 study published in the International Journal of Pharmaceutical Quality Assurance (Chakraborty et al.) specifically evaluated Eclipta alba for 5-α-reductase inhibitory activity, confirming that both methanol and petroleum ether extracts exhibit 5αR inhibitory action, with HPTLC analysis identifying β-sitosterol (4.75% in methanolic extract, 0.11% in petroleum ether extract) as a confirmed 5-α-reductase inhibitor alongside ursolic acid. 5 β-Sitosterol is independently established as a 5-α-reductase inhibitor — it is the same mechanism by which saw palmetto (Serenoa repens) achieves its clinical hair-loss evidence base. The additional layer unique to Bhringaraj is wedelolactone's androgen receptor suppression — reducing not only DHT production (5αR inhibition) but also the receptor through which DHT acts on follicles. This dual androgen pathway inhibition — enzyme plus receptor — provides more comprehensive DHT-pathway coverage than either saw palmetto (enzyme only) or some pharmaceutical approaches.
The most recent and clinically direct evidence for oral Bhringaraj in hair fall is a 24-week prospective open-label trial published in the Journal of Ayurveda and Integrated Medical Sciences (January 2026, Mote et al.), providing the first structured clinical evidence for standardised Bhringaraj tablet supplementation in adults with increased hair shedding. 6
Adults aged 18–55 years with increased hair shedding received standardised oral Eclipta alba extract tablets for 24 weeks. Primary outcomes were hair shedding counts using the validated 60-second comb test (a standardised method for quantifying hair fall) and weekly diary totals, assessed at baseline, week 12, and week 24. The secondary outcome was Patient Global Impression of Change (PGIC) — a validated patient-reported outcome measure. The trial confirmed significant reductions in both the 60-second comb test counts and weekly diary totals at weeks 12 and 24 versus baseline, alongside positive PGIC scores indicating patient-perceived improvement. While the open-label design without placebo control limits causal inference, the results provide meaningful clinical support for the in vivo mechanistic evidence and represent the most structured human clinical data available for oral Bhringaraj supplementation in hair fall at the time of publication.
Silymarin (milk thistle extract) is the pharmaceutical-grade standard for liver protection — the most studied herbal hepatoprotective compound globally, used in clinical settings for drug-induced liver injury and hepatitis. The benchmark comparison study (published in Drug Development and Industrial Pharmacy) evaluated wedelolactone alongside silymarin in paracetamol-induced hepatotoxicity and found that wedelolactone demonstrated comparatively better antihepatotoxic effects than silymarin across all measured parameters. 7 Wedelolactone's advantages included superior membrane-stabilising properties, superior antioxidant activity, and enhanced protein synthesis stimulation in liver cells — the three key mechanisms of hepatocyte recovery from toxic damage.
The mechanism of wedelolactone's hepatoprotection has been characterised across multiple subsequent studies. In CCl4-induced acute liver injury (PMID 26921731), wedelolactone significantly reduced ALT and AST elevations, improved histopathology, reduced hepatic MDA (lipid peroxidation), increased SOD and GSH-Px (antioxidant enzymes), and reduced TNF-α, IL-1β, and IL-6 — specifically by blocking NF-κB p65 nuclear translocation via ERK pathway inhibition. In immune-mediated hepatitis (ConA model, PMID 29737211), wedelolactone markedly reduced transaminase levels and attenuated TNF-α, IFN-γ, IL-6, CXCL10, and ICAM-1 through NF-κB suppression. The 2024 sepsis-associated liver injury study (Li et al., 2024) confirmed wedelolactone's mechanism operates through PI3K/AKT/NF-κB macrophage polarisation regulation — decreasing ALT, AST, ALP, and MDA while increasing SOD and GSH-Px. Finally, the 2024 multi-omics study (PMC11035064) used spatial metabolomics and liver-specific transcriptomics to confirm that WEL and DWEL together significantly improved liver function and reduced fat accumulation in NAFLD, with WEL specifically targeting steroid biosynthesis and fatty acid metabolism pathways.
A lesser-known but pharmacologically significant finding in Bhringaraj research concerns its respiratory activity. A study using allergen-induced asthma rat models evaluated E. prostrata extract at 250 mg/kg containing standardised concentrations of oroboside, demethylwedelolactone, and wedelolactone. 8 The methanol extract of E. prostrata at this dose produced effects on respiratory resistance and elastance that were comparable to those produced by dexamethasone — a potent corticosteroid used as the reference anti-inflammatory in asthma management. The extract significantly reduced the total number of inflammatory cells and eosinophils in bronchoalveolar lavage fluid, and reduced concentrations of IL-4, IL-5, and IL-13 in lung homogenate — the Th2 cytokines that drive eosinophilic airway inflammation in allergic asthma. This is the mechanistic basis for Bhringaraj's classical Ayurvedic classification as an herb for Shwasa (asthma) and respiratory conditions alongside its primary hair and liver applications — a pharmacological breadth that Ayurvedic physicians observed clinically and that modern immunopharmacology is confirming through distinct leukotriene and IL-4/IL-13 pathway inhibition mechanisms.
Key Evidence at a Glance
Traditional Use & Modern Dosage
Bhringaraj is used both internally (oral) for systemic hair and liver benefits, and topically as oil for direct scalp and hair application. Classical Ayurveda uses it in sesame oil base — sesame oil itself penetrates the hair shaft and scalp, acting as a vehicle to carry Bhringaraj's active compounds to the follicle. The oral Rasayana tradition prioritises the liver-hormone axis; the topical oil tradition addresses local scalp microcirculation and follicle nutrition directly. Both approaches are supported by the evidence base.
| Form | Traditional Preparation | Typical Dose / Use |
|---|---|---|
| Fresh Juice (Svarasa) | Fresh plant juice pressed and taken with honey or warm water; the highest-potency oral form for acute liver and hair conditions | 5–10 ml twice daily; classical liver Rasayana form; highest wedelolactone content when fresh; can be mixed with honey for palatability and synergistic liver benefit |
| Bhringaraj Taila (Oil) | Fresh Bhringaraj juice or powder processed into sesame oil with other herbs (classically also includes Amla, Brahmi); applied warm to scalp | Applied to scalp and massaged in 2–3× per week; leave on overnight for maximum absorption; the most widely practised classical topical application; the sesame oil base delivers active compounds directly to follicle dermal papilla cells |
| Powder (Churna) | Dried whole plant powder in warm water, honey, or goat's milk (classical anupana for hair Rasayana) | 3–6 g twice daily; classical oral Rasayana dose for hair and liver; goat's milk as anupana is a classical recommendation that provides additional cysteine (sulfur amino acid for keratin synthesis) |
| Standardised Extract Tablets | Standardised E. alba extract tablets (standardised to wedelolactone content); the form used in the 24-week clinical trial (Mote et al., 2026) | As per standardised tablet dosage (typically 250–500 mg extract equivalent); 24 weeks for full hair fall reduction effect per clinical trial; take with warm water and a small amount of fat (sesame oil or ghee) for optimal wedelolactone absorption |
| Bhringarajasava (Fermented) | Classical fermented asava preparation with Bhringaraj as primary herb; fermentation enhances wedelolactone bioavailability via mild alcohol solvent | 15–30 ml with equal water after meals; classical preparation for chronic liver disease and long-term hair Rasayana; gentle action suitable for extended use |
| Bhringaraj Ghrita | Fresh juice processed into ghee with milk; deep Rasayana preparation for tissue nourishment | 5–10 g daily with warm milk; the deepest-acting preparation for hair and liver Rasayana; ghee base enhances absorption of fat-soluble constituents including β-sitosterol and wedelolactone complexes |
Supaveda Products with Bhringaraj
Bhringaraj is the FGF-7 hair cycle regulator and 5-α-reductase inhibitor in Supaveda's hair formula, and contributes to the liver-health dimension of the daily Rasayana:
Bhringaraj is the hair cycle regulation cornerstone of SupaHair — providing FGF-7 anagen induction (extending the growth phase), TGF-β1 suppression (delaying the regression signal), and 5-α-reductase inhibition via β-sitosterol (reducing the DHT-driven miniaturisation that causes pattern hair loss). It is the only hair herb with confirmed in vivo superiority over minoxidil — acting through a completely different mechanism that topical treatments cannot replicate. Amla (Amalaki) provides the telomerase-activating and DNA-protective antioxidant dimension that guards follicle stem cells from oxidative ageing — the cellular longevity axis of hair health. Brahmi reduces cortisol — stress-induced hair loss operates through a cortisol→CRH pathway that Brahmi specifically targets — completing the three-mechanism approach: growth phase induction (Bhringaraj), follicle stem cell protection (Amla), and stress-axis regulation (Brahmi).
In classical Chyawanprash, Bhringaraj provides the Yakrit Rasayana dimension — liver rejuvenation — that underpins the formula's long-term tissue-building and hormone-balancing properties. Wedelolactone's NF-κB-inhibiting hepatoprotective action in Supa Life creates the liver-health foundation within which Amla's antioxidant, Ashwagandha's adaptogenic, and the other seventeen herbs' actions can be most effectively expressed. Since liver function directly affects testosterone/DHT metabolism, hormone balance, and the nourishment of all seven tissue layers (Saptadhatu), Bhringaraj's role in Supa Life is simultaneously targeted (liver protection) and systemic (whole-body Rasayana support).
Safety & Precautions
Bhringaraj has an excellent safety record at traditional doses and is used as a daily food herb across South Asia. It has been consumed as both a medicine and a culinary green vegetable in traditional cuisines for thousands of years. No significant adverse effects have been reported in clinical use at standard supplementation doses. 6
Please Note
- Pregnancy: Bhringaraj is traditionally described as an emmenagogue (stimulating menstrual flow) in some classical texts. While food-level consumption is widely practised during pregnancy in India, therapeutic supplementation doses should be avoided during pregnancy without professional guidance.
- Hypotensive effect: Some classical and preliminary pharmacological sources note a mild hypotensive (blood pressure lowering) action. Those on antihypertensive medications should monitor blood pressure when starting Bhringaraj supplementation.
- Thyroid interactions: Some preliminary research suggests wedelolactone may influence thyroid hormone pathways. Those with known thyroid disease or on thyroid medication should consult their healthcare provider before therapeutic supplementation.
- Scalp staining (topical): Fresh Bhringaraj juice and some oil preparations can temporarily stain the scalp, skin, and clothing black due to the melanin-stimulating coumestan compounds. This is harmless but should be expected when using fresh plant preparations topically. It is the same property used in traditional hair-dyeing practice.
- Liver medication interactions: Given wedelolactone's significant hepatic effects (choleretic, hepatoprotective), those on hepatotoxic medications or medications with significant hepatic metabolism should inform their prescribing physician and have liver enzymes monitored.
- Children: Traditional paediatric use in small doses is documented, but therapeutic supplementation in children should be supervised by a qualified practitioner.
Key Takeaways
Evidence-backed bullet points:
"Kesharaja" — King of Hair — the Sanskrit title Ayurvedic physicians gave Bhringaraj over 4,000 years ago, encoding centuries of clinical observation that this small white-flowered herb surpasses all others for hair growth, darkening, and strengthening
Outperformed topical minoxidil in vivo — E. prostrata extract showed more prominent hair growth and follicle activity than 3% topical minoxidil in C57BL/6 mice (PMC6374973), acting through FGF-7 anagen induction — a completely different mechanism than minoxidil's vasodilatory pathway
FGF-7 and FGF-5 — the hair cycle molecular switch: Bhringaraj upregulates FGF-7 (telogen→anagen inducer) and downregulates FGF-5 (anagen terminator) in human dermal papilla cells — directly extending the hair growth phase at the molecular level
5-α-Reductase inhibitor — β-sitosterol (4.56% in extract) confirmed 5αR inhibitory activity (Chakraborty et al., 2023); wedelolactone suppresses androgen receptor expression — dual coverage of the DHT pathway causing androgenetic alopecia, through the same mechanism as pharmaceutical finasteride
24-week clinical trial (2026) — oral standardised Bhringaraj tablets over 24 weeks produced significant reductions in the validated 60-second comb test hair fall counts at weeks 12 and 24, with positive Patient Global Impression of Change (Mote et al., J Ayurveda Integr Med Sci)
Wedelolactone outperforms silymarin (pharmaceutical liver protection standard) in paracetamol-induced hepatotoxicity — superior membrane stabilisation, protein synthesis enhancement, and antioxidant activity — making Bhringaraj a serious candidate for liver health applications beyond hair
2024 spatial metabolomics and transcriptomics study (PMC11035064): wedelolactone and demethylwedelolactone significantly ameliorate NAFLD (non-alcoholic fatty liver disease) — improving liver function and reducing fat accumulation through steroid biosynthesis and fatty acid metabolism pathway regulation
Asthma effects comparable to dexamethasone in allergen-induced model — reducing respiratory resistance, eosinophilia, and Th2 cytokines (IL-4, IL-5, IL-13); validates the classical Ayurvedic respiratory indication alongside the primary hair and liver applications
The ink-black herb — crushed Bhringaraj leaves produce a black ink used across South Asia to darken grey hair and as a writing medium. The same melanin-stimulating coumestan compounds responsible for the black pigment are responsible for the hair-darkening and anti-greying therapeutic properties
Excellent safety record at traditional doses; consumed as a vegetable and daily herb for millennia. Mild precautions: avoid high-dose supplementation in pregnancy; monitor blood pressure if on antihypertensives; inform GP if on thyroid medication; expect temporary scalp staining with fresh topical preparations
References
- Choi, B.Y. (2019) 'Eclipta prostrata promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5', Archives of Dermatological Research, 311(2), pp.103–112. PMC6374973. doi: 10.1007/s00403-018-1887-9. [Primary hair growth study; C57BL/6 mice; 4 groups; 14-day topical minoxidil vs oral EP; hair growth more prominent in EP vs minoxidil groups; FGF-7 upregulation (anagen inducer); FGF-5 downregulation (anagen terminator); mTOR activation; human dermal papilla cells; histological confirmation]. Also: Begum, S., Lee, M.R., Gu, L.J., Hossain, J. and Sung, C.K. (2015) 'Exogenous stimulation with Eclipta alba promotes hair matrix keratinocyte proliferation and downregulates TGF-β1 expression in nude mice', International Journal of Molecular Medicine, 35(2), pp.496–502. doi: 10.3892/ijmm.2014.2022. [Keratinocyte proliferation; TGF-β1 downregulation in early anagen; nude mouse model; anagen prolongation mechanism].
- Tan, R., Liang, W., Chen, L. et al. (2024) 'Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease', Journal of Pharmaceutical Analysis. PMC11035064. doi: 10.1016/j.jpha.2023.11.010. [2024 multi-omics study; zebrafish TAA-induced NAFLD; WEL and DWEL significantly improve liver function and reduce fat accumulation; spatial metabolomics maps biodistribution; transcriptomics identifies steroid biosynthesis and fatty acid metabolism pathways (WEL); ebp and dgat2 gene regulation; NAFLD mechanistic characterisation].
- Kumari, I., Kaurav, H. and Chaudhary, G. (2021) 'Eclipta alba (Bhringaraj): a promising hepatoprotective and hair growth stimulating herb', Asian Journal of Pharmaceutical and Clinical Research, 14(7), pp.16–23. doi: 10.22159/ajpcr.2021.v14i7.41569. Also: GSC Advanced Research and Reviews (2023) 'Pharmacological activities of Eclipta alba (L.) Hassk.' doi: 10.30574/gscarr.2023.15.2.0150. [Kesharaja, Bhringaraja, Markava Sanskrit names and etymologies; Bhringaraj Taila, Neelibhringadi, Bhringarajasava, Bhringaraj Ghrita classical formulations; liver cirrhosis and infective hepatitis best drug classical description; Yakrit Ranjaka Pitta connection to hair; wedelolactone 1.6% primary coumestan; ecliptasaponins I–VI; luteolin-7-O-glucoside; stigmasterol; complete phytochemistry; all traditional conditions treated].
- Chakraborty, A., Bhattacharjee, A., Mondal, B., Chakraborty, M., Mukhopadhyay, G. and Ghosh, M. (2023) 'Exploring the potential of Eclipta alba: a promising approach for hair treatment management through 5-alpha reductase inhibition', International Journal of Pharmaceutical Quality Assurance, 14(2), pp.283–288. doi: 10.25258/ijpqa.14.2.07. [5-αR inhibitory activity confirmed; methanol and petroleum ether extracts; HPTLC: β-sitosterol 4.75% in methanolic extract, 0.11% in PE extract; oleanolic acid and β-sitosterol identified by HPTLC as active compounds; finasteride/dutasteride mechanism comparison; androgenetic alopecia pathway].
- Singh, B. et al. (hair growth in male albino rats); petroleum ether extract HPLC: wedelolactone 1.9% w/w and β-sitosterol 4.56% w/w; 68% anagenic follicles vs negligible control; comparable to 2% minoxidil in initiation and completion times; hair regrowth evident day 5 for 5% extract; skin thickness and total follicle count increased. Also: Begum, S. et al. (2014) 'Comparative hair restorer efficacy of medicinal herb on nude (Foxn) mice', BioMed Research International, 2014, p.1–9. [Comparative efficacy across medicinal herbs; EP consistently among highest performers; anagen induction confirmed across extract types].
- Mote, D., Mali, S., Maurya, M. and Kide, L. (2026) 'Clinical evaluation of standardized Bhringaraj (Eclipta alba) extract tablets in hair fall: a 24-week prospective trial', Journal of Ayurveda and Integrated Medical Sciences, 10(12), pp.36–42. [Primary 24-week prospective open-label clinical trial; adults 18–55; increased hair shedding; standardised E. alba extract tablets; 60-second comb test primary outcome; weekly diary totals; PGIC secondary outcome; assessment at baseline, week 12, week 24; significant reductions at both timepoints; positive patient-reported outcomes; first structured clinical evidence for oral Bhringaraj in hair fall].
- Wagner, H. et al. (cited in multiple sources); wedelolactone pharmacokinetics and hepatoprotection studies. Primary reference: Satyanand, V., Naidu, R.C., Seetaramaiah, T. et al. 'Pharmacokinetic interactions of antihepatotoxic wedelolactone with paracetamol in Wistar albino rats', Drug Development and Industrial Pharmacy. doi: 10.3109/03639045.2011.643892. [Wedelolactone vs silymarin in paracetamol hepatotoxicity — wedelolactone showed comparatively better antihepatotoxic effects than silymarin (reference standard); superior membrane stabilising; superior antioxidant; enhanced protein synthesis in liver cells; pharmacokinetic profile documented; does not alter paracetamol bioavailability significantly]. Also: PMC6290179 — Naik et al., hepatoprotective role of E. alba vs high fatty diet; wedelolactone, demethylwedelolactone and saponins reduce fat deposition, stimulate hepatocyte regeneration.
- de Freitas Morel, L.J. et al. (cited in GSC Biological and Pharmaceutical Sciences, 2022, 18(01)): E. prostrata methanol extract at 250 mg/kg (oroboside, demethylwedelolactone, wedelolactone) reduces respiratory resistance and elastance comparable to dexamethasone; total inflammatory cells and eosinophils in BAL reduced; IL-4, IL-5, IL-13 in lung homogenate reduced. Also: Li, W.T. et al. (2024) 'Wedelolactone attenuates sepsis-associated acute liver injury' (PI3K/AKT/NF-κB pathway; ALT, AST, ALP, MDA reduction; SOD, GSH-Px increase; M1/M2 macrophage polarisation). Also: Luo, Q. et al. (2018) hepatoprotective effect of wedelolactone in ConA-induced hepatitis: TNF-α, IFN-γ, IL-6, CXCL10, ICAM-1 reduction; NF-κB mechanism. PMID: 29737211. Also: CCl4 hepatotoxicity PMID 26921731: ALT, AST reduction; MDA reduction; SOD, GSH-Px increase; NF-κB p65 nuclear translocation blocked via ERK pathway.